Aliri’s team of technical experts and dedicated scientists utilize their vast experience and cutting-edge technologies to solve complex problems in bioanalysis, delivering fast and reliable drug discovery solutions. Get to know our industry experts and their areas of expertise below.
Filter by area of expertise
David BonnelGlobal Executive Director
Education
University of Lille, France: PhD Biology and Health University of Sherbrooke, Canada: PhD Biochemistry
Years of Experience
12+
Area of Expertise
- Dermatology
- Discovery
- Drug localization
- Efficacy biomarkers
- Mass spectrometry
- Mass spectrometry by MALDI
- Oncology
- Process improvement
- Small molecule APIs
- Spatial bioanalysis
- Spatial biology
- Strategy and process development
- Endogenous compounds
Ed BrewerSr. Director R&D Mass Spec
Education
State University of New York College at Oswego - MS in Chemistry
Years of Experience
30+
Area of Expertise
- ACDs
- Bioavailability
- Discovery
- Efficacy biomarkers
- GLP pre-clinical / clinical studies
- HRMS
- Import/export
- Large molecule
- LC/MS-MS
- Lead optmization
- M-10 guidance
- Mass spectrometry
- Method development/validation
- Non-GLP / non-clinical studies
- Non-proprietary assays
- Oligonucleotide
- Oncology
- PK/TK
- Process improvement
- Program management
- Proteins & peptides
- QA/QC
- Regulatory compliance
- Sample access
- Scale-up
- Small molecule APIs
- Strategy and process development
- Endogenous compounds
- Chiral compounds
- CVM studies
Mathieu GaudinLabatory Director, Spatial Bioanalysis
Education
Universite Paris Descartes: PhD Analytical Chemistry Ecole nationale superieure de Chimie de Rennes: Chemical Engineering
Years of Experience
12
Area of Expertise
- Bioavailability
- Dermatology
- Drug localization
- Efficacy biomarkers
- HRMS
- Import/export
- LC/MS-MS
- Mass spectrometry
- Mass spectrometry by MALDI
- Method development/validation
- Non-GLP / non-clinical studies
- PK/TK
- Process improvement
- Small molecule APIs
- Spatial bioanalysis
- Spatial biology
- Endogenous compounds
Shane KarnikSenior Laboratory Director, Bioanalytical
Education
University of Colorado Springs: Masters of Science, Chemistry
Years of Experience
25+
Area of Expertise
- Bioavailability
- Dermatology
- Discovery
- Efficacy biomarkers
- GLP pre-clinical / clinical studies
- HRMS
- Large molecule
- LC/MS-MS
- M-10 guidance
- Mass spectrometry
- Method development/validation
- Non-GLP / non-clinical studies
- Non-proprietary assays
- Oligonucleotide
- Oncology
- Process improvement
- Program management
- Proteins & peptides
- Regulatory compliance
- RNA
- Small molecule APIs
- Strategy and process development
- MAB by Mass Spectrometry
- Endogenous compounds
- Chiral compounds
- CVM studies
Jenifer MihelichDirector of Quality Assurance
Education
University of Colorado, Colorado Springs; BA, Biochemistry
Years of Experience
18
Area of Expertise
- GLP pre-clinical / clinical studies
- M-10 guidance
- Process improvement
- QA/QC
- Regulatory compliance
- CVM studies
Kimberly MilazzoGeneral Manager
Education
MBA (2010) University of Colorado Pre-Med/Health Science (2005)
University of Colorado BA Psychology (1998)
University of Texas
Years of Experience
16+
Area of Expertise
- Discovery
- GLP pre-clinical / clinical studies
- Lead optmization
- M-10 guidance
- Method development/validation
- Non-GLP / non-clinical studies
- Non-proprietary assays
- PK/TK
- Process improvement
- Program management
- QA/QC
- Regulatory compliance
- Scale-up
- Strategy and process development
- CVM studies
Diane PollockManager, Sample Management and Archives
Education
Cyprus High School
Years of Experience
25+
Area of Expertise
- Non-GLP / non-clinical studies
- Process improvement
- Sample access
Corinne RamosR&D Director
Education
University Paul Sabatier, Toulouse, France: PhD Molecular Biology Post Doctorate, NIH, Bethesda, MD, USA MBA Johns Hopkins University, Baltimore MD, USA
Years of Experience
15+
Area of Expertise
- Discovery
- Drug localization
- Efficacy biomarkers
- GLP pre-clinical / clinical studies
- Large molecule
- Method development/validation
- Non-GLP / non-clinical studies
- Non-proprietary assays
- Oligonucleotide
- Oncology
- Proteins & peptides
- RNA
- Spatial bioanalysis
- Spatial biology
Scott ReuschelSenior Director; Site Lead
Education
University of Alabama at Birmingham: Masters of Science, Forensic Science
Years of Experience
33
Area of Expertise
- Bioavailability
- Discovery
- Efficacy biomarkers
- GLP pre-clinical / clinical studies
- HRMS
- LC/MS-MS
- Lead optmization
- M-10 guidance
- Mass spectrometry
- Method development/validation
- Non-GLP / non-clinical studies
- Non-proprietary assays
- Oligonucleotide
- PK/TK
- Process improvement
- Program management
- QA/QC
- Regulatory compliance
- RNA
- Sample access
- Small molecule APIs
- Strategy and process development
- UPLC-FD
- Endogenous compounds
- Chiral compounds
Cindy RewertsSenior Advisor
Education
BS -Colorado State University MS -University of North Carolina -Chapel Hill
Years of Experience
35
Area of Expertise
- Bioavailability
- Dermatology
- Discovery
- GLP pre-clinical / clinical studies
- LC/MS-MS
- Lead optmization
- Non-GLP / non-clinical studies
- Non-proprietary assays
- Oncology
- PK/TK
- Process improvement
- Program management
- Small molecule APIs
- Strategy and process development
Bonnie RichardsonQA Manager, GLP/GCP
Education
BS University of Utah, Chemistry with a biological emphasis
Years of Experience
20
Area of Expertise
- Bioavailability
- Discovery
- GLP pre-clinical / clinical studies
- HRMS
- LC/MS-MS
- M-10 guidance
- Mass spectrometry
- Method development/validation
- Non-GLP / non-clinical studies
- Non-proprietary assays
- Oligonucleotide
- Process improvement
- Program management
- Proteins & peptides
- QA/QC
- Regulatory compliance
- UPLC-FD
- Endogenous compounds
- Chiral compounds
Juan RognessDirector, Study Managment and Study Coordination
Education
University of Mississippi, School of Pharmacy, M.S. Chongqing University of Medical Sciences, M.D; School of Pharmacology, M.S.
Years of Experience
27
Area of Expertise
- Bioavailability
- Discovery
- Efficacy biomarkers
- GLP pre-clinical / clinical studies
- LC/MS-MS
- Lead optmization
- M-10 guidance
- Mass spectrometry
- Method development/validation
- Non-GLP / non-clinical studies
- Non-proprietary assays
- Oligonucleotide
- PK/TK
- Process improvement
- Program management
- QA/QC
- Regulatory compliance
- RNA
- Sample access
- Small molecule APIs
- Strategy and process development
- UPLC-FD
- Endogenous compounds
- Chiral compounds
Mark VannOperations Support Manager
Education
Massachusetts College of Art & Design: Bachelor of Fine Arts in Art History / Art
Years of Experience
5+
Area of Expertise
- Import/export
- Sample access
- Scale-up
- Strategy and process development
Troy VoelkerDirector of Labatory Operations
Education
University of Montana: PhD Organic Medicinal Chemistry Post Doctorate: Human Biomolecular Research Institute
Years of Experience
19
Area of Expertise
- ACDs
- Bioavailability
- Dermatology
- Discovery
- Efficacy biomarkers
- GLP pre-clinical / clinical studies
- HRMS
- LC/MS-MS
- Lead optmization
- M-10 guidance
- Mass spectrometry
- Method development/validation
- Non-GLP / non-clinical studies
- Non-proprietary assays
- Oligonucleotide
- Oncology
- Process improvement
- Program management
- Proteins & peptides
- Regulatory compliance
- RNA
- Small molecule APIs
- Strategy and process development
- UPLC-FD
- Endogenous compounds
- Chiral compounds
Adam WinstromDirector Client and Study Managment
Education
BS Physiology Michigan State
Years of Experience
15+
Area of Expertise
- Bioavailability
- Discovery
- GLP pre-clinical / clinical studies
- Lead optmization
- Non-GLP / non-clinical studies
- PK/TK
- Process improvement
- Program management
- Strategy and process development
- CVM studies